Angiotensin receptor blockade in the anterior hypothalamic area inhibits stress-induced pressor responses in rats. 2001

T Kubo, and H Numakura, and S Endo, and Y Hagiwara, and R Fukumori
Department of Pharmacology, Showa Pharmaceutical University, Machida, Tokyo, Japan. kubo@ac.shoyaku.ac.jp

Central angiotensin systems are involved in expression of pressor responses induced by immobilization stress. In this study, we examined whether angiotensin receptors in the anterior hypothalamic area are involved in the pressor response during stress exposure in rats. Intracerebroventricular injections of the angiotensin AT1-receptor antagonist losartan (6.5 and 22 nmol) attenuated pressor responses to immobilization stress dose-dependently. Injections of losartan (0.065 and 0.22 nmol) into the anterior hypothalamic area also suppressed the stress-induced pressor response dose-dependently, whereas intraventricular injection of losartan (2.2 nmol) did not affect it. Immobilization stress caused increases in plasma catecholamine levels. The stress-induced increase of plasma catecholamine levels was also inhibited by angiotensin receptor blockade in the anterior hypothalamic area. The present results suggest that angiotensin receptors in the anterior hypothalamic area are involved in expression of the pressor response and sympathetic activation induced by immobilization stress.

UI MeSH Term Description Entries
D007025 Anterior Hypothalamic Nucleus Loose heterogeneous collection of cells in the anterior hypothalamus, continuous rostrally with the medial and lateral PREOPTIC AREAS and caudally with the TUBER CINEREUM. Anterior Hypothalamic Area,Hypothalamic Area, Anterior,Nucleus Anterior Hypothalami,Anterior Hypothalami, Nucleus,Anterior Hypothalamic Areas,Anterior Hypothalamus, Nucleus,Area, Anterior Hypothalamic,Areas, Anterior Hypothalamic,Hypothalami, Nucleus Anterior,Hypothalamic Areas, Anterior,Hypothalamic Nucleus, Anterior,Hypothalamus, Nucleus Anterior,Nucleus Anterior Hypothalamus,Nucleus, Anterior Hypothalamic
D008297 Male Males
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D012149 Restraint, Physical Use of a device for the purpose of controlling movement of all or part of the body. Splinting and casting are FRACTURE FIXATION. Immobilization, Physical,Physical Restraint,Physical Immobilization,Physical Restraints,Restraints, Physical
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D000809 Angiotensins Oligopeptides which are important in the regulation of blood pressure (VASOCONSTRICTION) and fluid homeostasis via the RENIN-ANGIOTENSIN SYSTEM. These include angiotensins derived naturally from precursor ANGIOTENSINOGEN, and those synthesized. Angiotensin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

T Kubo, and H Numakura, and S Endo, and Y Hagiwara, and R Fukumori
April 1996, Experientia,
T Kubo, and H Numakura, and S Endo, and Y Hagiwara, and R Fukumori
March 2000, Hypertension research : official journal of the Japanese Society of Hypertension,
T Kubo, and H Numakura, and S Endo, and Y Hagiwara, and R Fukumori
January 1982, Hypertension (Dallas, Tex. : 1979),
T Kubo, and H Numakura, and S Endo, and Y Hagiwara, and R Fukumori
January 1983, Hypertension (Dallas, Tex. : 1979),
T Kubo, and H Numakura, and S Endo, and Y Hagiwara, and R Fukumori
January 1997, Life sciences,
T Kubo, and H Numakura, and S Endo, and Y Hagiwara, and R Fukumori
January 1982, Neuroendocrinology,
T Kubo, and H Numakura, and S Endo, and Y Hagiwara, and R Fukumori
April 2007, Neuroscience letters,
T Kubo, and H Numakura, and S Endo, and Y Hagiwara, and R Fukumori
July 2020, Cellular and molecular neurobiology,
T Kubo, and H Numakura, and S Endo, and Y Hagiwara, and R Fukumori
January 1997, Brain research,
T Kubo, and H Numakura, and S Endo, and Y Hagiwara, and R Fukumori
August 1998, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!